An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum-Reference-Cited by-同舟云学术

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum

Published:2020-12-18 Issue:3 Volume:17 Page:431-445
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Van Hulle Carol¹²,Jonaitis Erin M.¹³,Betthauser Tobey J.¹²,Batrla Richard⁴,Wild Norbert⁵,Kollmorgen Gwendlyn⁵,Andreasson Ulf⁶,Okonkwo Ozioma¹²³,Bendlin Barbara B.¹²³,Asthana Sanjay¹²⁷,Carlsson Cynthia M.¹²³⁷,Johnson Sterling C.¹²³⁷,Zetterberg Henrik⁶⁸⁹¹⁰,Blennow Kaj⁶⁸

Affiliation:

1. Wisconsin Alzheimer's Disease Research Center School of Medicine and Public Health University of Wisconsin‐Madison Madison Wisconsin USA

2. Department of Medicine School of Medicine and Public Health University of Wisconsin‐Madison Madison Wisconsin USA

3. Wisconsin Alzheimer's Institute School of Medicine and Public Health University of Wisconsin‐Madison Madison Wisconsin USA

4. Roche Diagnostics International AG Rotkreuz Switzerland

5. Roche Diagnostics GmbH Penzberg Germany

6. Department of Psychiatry and Neurochemistry Institute of Neuroscience and Physiology the Sahlgrenska Academy at the University of Gothenburg Mölndal Sweden

7. Geriatric Research Education and Clinical Center at the William S. Middleton Memorial Veterans Hospital Madison Wisconsin USA

8. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden

9. Department of Neurodegenerative Disease UCL Institute of Neurology London UK

10. UK Dementia Research Institute at UCL London UK

Funder

Vetenskapsrådet

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12204

Reference48 articles.

1. Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Aβ(1‐42), pTau and tTau CSF immunoassays;Blennow K;Sci Rep,2019

2. Tangles and plaques in nondemented aging and ?preclinical? Alzheimer's disease

3. Neuropathological stageing of Alzheimer-related changes

4. The Past and the Future of Alzheimer’s Disease Fluid Biomarkers1

5. Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tau pathology mediated the plasma biomarkers and cognitive function in patients with mild cognitive impairment;Experimental Gerontology;2024-10

2. Gut microbiome compositional and functional features associate with Alzheimer’s disease pathology;2024-09-05

3. Alzheimer’s Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy;Brain Sciences;2024-08-26

4. CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer's disease;Alzheimer's & Dementia;2024-07-19

5. Longitudinal plasma phosphorylated‐tau217 and other related biomarkers in a non‐demented Alzheimer's risk‐enhanced sample;Alzheimer's & Dementia;2024-07-05